In terms of revenue, the global alopecia (hair loss) treatment market was valued at $2512.12 million in 2020 and is expected to reach $3773.54 million by 2028, growing at a CAGR of 4.56% during the forecast period. The market study has also analyzed the impact of COVID-19 on the alopecia (hair loss) treatment industry qualitatively and quantitatively.

GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2021-2028

Global Alopecia (Hair Loss) Treatment Market by Gender (Female, Male) Market by Indications (Androgenic Alopecia, Alopecia Areata, Alopecia Totalis, Other Indications) Market by Distribution Channels (Drug Stores & Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Market by Treatment (Topical, Oral, Other Treatment Types) by Geography.

Request free sample

In terms of revenue, the global alopecia (hair loss) treatment market was valued at $2512.12 million in 2020 and is expected to reach $3773.54 million by 2028, growing at a CAGR of 4.56% during the forecast period. The market study has also analyzed the impact of COVID-19 on the alopecia (hair loss) treatment industry qualitatively and quantitatively.

ALOPECIA HAIR LOSS TREATMENT MARKET

To know more about this report, request a free sample copy

Key enablers of the global alopecia (hair loss) treatment market growth are:

  • Rising autoimmune diseases
    • The pervasiveness of autoimmune diseases is increasing worldwide. According to the National Stem Cell Foundation estimation, approximately 4% of the global population is affected by at least one of the 80 different autoimmune diseases.
    • Some autoimmune diseases causing alopecia are Alopecia Areata, cancer, Lupus, Hashimoto’s Disease, Graves’ disease, and psoriasis. Such aspects fuel the demand for the treatment of alopecia.
  • High consumption of alcohol and tobacco
  • Unhealthy dietary habits
  • Stress and changing lifestyles

Key factors restraining the market growth are:

  • Risk of infections or side effects
    • Fear about medications like Finasteride having possible side effects like skin rash, ejaculation disorder, and risk of prostate cancer act as restraints.
    • The risk of possible infection on the scalp after hair transplant surgery builds fear in the patient to get treated. Also, a 100% success rate is not present currently for any kind of hair treatment therapies and medicines.
  • High costs

The report on the global alopecia (hair loss) treatment market includes the segmentation analysis of gender, indications, distribution channels, and treatment.

Market by Indications:

  • Androgenic Alopecia
    • In 2020, the androgen alopecia segment harbored the largest market share in the market by indications.
    • Androgenic alopecia is a genetic hair loss condition that can affect men and women. In men, it can cause a declining hairline and steady disappearance of hair from the frontal scalp and crown, while, in women, excessive hair thinning is observed.
  • Alopecia Areata
  • Alopecia Totalis
  • Other Indications

Geographically, the global alopecia (hair loss) treatment market has been segmented on the basis of four major regions, which includes:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Russia, Belgium, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
    • Asia Pacific is anticipated to be the fastest-growing market with a CAGR of 5.36% during the forecast period, owing to the booming market for hair loss treatment in major economies, such as China, India, and Japan.
    • The increasing consumer inclination towards personal aesthetics and robust marketing strategies by hair clinics and pharmaceutical companies boosts market demands.
    • Moreover, the region has pharmaceutical companies like Sun Pharmaceutical Industries Ltd and Shiseido Company Ltd, performing clinical trials on potential medical treatment of hair loss.
  • Rest of World: Latin America, Middle East & Africa

The major players in the global alopecia (hair loss) treatment market are:

  • Teva Pharmaceuticals Industries Ltd
  • Merk & Co Inc
  • Cipla Ltd
  • Johnson and Johnson
  • Sun Pharmaceutical Industries Ltd
  • Other companies

Key strategies adopted by some of these companies:

In January 2018, Teva Pharmaceutical Industries Ltd and Paxman entered into a licensing agreement for PAXMAN Scalp Cooler treatments for cancer patients in the Mexico market. In October 2019, Cellmid signed a distribution agreement with Aeon International for évolis® Professional to be sold in the Chinese cross-border e-commerce market.

Furthermore, in January 2018, HAiROOTZ was launched in India by Dr. Reddy Laboratories Ltd. It prevents excessive hair loss. It provides minerals that reduce hair thinning, breakage, and prevent dandruff and greying.

Key findings of the global alopecia (hair loss) treatment market:

  • Stems cell hair transplantation is an upcoming trend for treating alopecia. The method is in the clinical trial phase and is considered a potential treatment of different hair loss conditions.
  • Advanced AI embedded in the Robotic Hair restoration system improves the performance and accuracy of hair transplant procedures to provide natural-looking hairs to patients.

 

Frequently Asked Questions (FAQs):

  • Which indications of alopecia are covered in the report?

A: Androgenic alopecia, Alopecia Areata, Alopecia Totalis, and other indications are covered in the report.

  • Which are the key regional markets for the alopecia (hair loss) treatment?

A: Emerging economies in Asia-Pacific are the key regional markets for alopecia (hair loss) treatment.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • RISE IN AUTOIMMUNE DISEASES
      • HIGH CONSUMPTION OF ALCOHOL AND TOBACCO
      • UNHEALTHY DIETARY HABITS
      • STRESS AND CHANGING LIFESTYLES
    • KEY RESTRAINTS
      • RISK OF INFECTIONS OR SIDE EFFECTS
      • HIGH COSTS
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON ALOPECIA (HAIR LOSS) TREATMENT MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY GENDER
    • FEMALE
    • MALE
  3. MARKET BY INDICATIONS
    • ANDROGENIC ALOPECIA
    • ALOPECIA AREATA
    • ALOPECIA TOTALIS
    • OTHER INDICATIONS
  4. MARKET BY DISTRIBUTION CHANNELS
    • DRUG STORES & RETAIL PHARMACIES
    • HOSPITAL PHARMACIES
    • ONLINE PHARMACIES
  5. MARKET BY TREATMENT
    • TOPICAL
      • MINOXIDIL
      • SHAMPOOS
    • ORAL
      • FINASTERIDE
      • OTHER ORAL HAIR LOSS TREATMENT
    • OTHER TREATMENT TYPES
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS & DIVESTITURES
    • COMPANY PROFILES
      • ACLARIS THERAPEUTICS
      • CELLMID
      • CIPLA LTD
      • CONCERT PHARMACEUTICALS
      • DAIICHI SANKYO
      • REDDY’S LABORATORIES
      • JOHNSON AND JOHNSON
      • LEXINGTON INTERNATIONAL
      • MERK & CO INC
      • SHISEIDO COMPANY LIMITED
      • SUN PHARMACEUTICAL INDUSTRIES LTD
      • TAISHO PHARMACEUTICALS CO LTD THE HIMALAYA DRUG COMPANY
      • TEVA PHARMACEUTICALS INDUSTRIES LTD
      • THE HIMALAYA DRUG COMPANY
      • TRANSITION HAIR PVT LTD

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – ALOPECIA (HAIR LOSS) TREATMENT MARKET

TABLE 2: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL FEMALE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL FEMALE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL MALE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL MALE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL ANDROGENIC ALOPECIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL ANDROGENIC ALOPECIA MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL ALOPECIA AREATA MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL ALOPECIA AREATA MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL ALOPECIA TOTALIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: GLOBAL ALOPECIA TOTALIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: GLOBAL OTHER INDICATIONS TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: GLOBAL OTHER INDICATIONS TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: GLOBAL DRUG STORES & RETAIL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 21: GLOBAL DRUG STORES & RETAIL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: GLOBAL HOSPITAL’ PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 23: GLOBAL HOSPITAL’ PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 24: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 25: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 26: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 27: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 28: GLOBAL TOPICAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 29: GLOBAL TOPICAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 30: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: GLOBAL MINOXIDIL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 33: GLOBAL MINOXIDIL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 34: GLOBAL SHAMPOOS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 35: GLOBAL SHAMPOOS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 36: GLOBAL ORAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: GLOBAL ORAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 38: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 39: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 40: GLOBAL FINASTERIDE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 41: GLOBAL FINASTERIDE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 42: GLOBAL OTHER ORAL HAIR LOSS TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 43: GLOBAL OTHER ORAL HAIR LOSS TREATMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 44: GLOBAL OTHER TREATMENT TYPES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 45: GLOBAL OTHER TREATMENT TYPES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 46: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 47: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 48: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 49: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 50: LEADING PLAYERS OPERATING IN NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET

TABLE 51: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 52: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 53: LEADING PLAYERS OPERATING IN EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET

TABLE 54: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 55: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 56: LEADING PLAYERS OPERATING IN ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET

TABLE 57: REST OF WORLD ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 58: REST OF WORLD ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 59: LEADING PLAYERS OPERATING IN REST OF WORLD ALOPECIA (HAIR LOSS) TREATMENT MARKET

TABLE 60: LIST OF MERGERS & ACQUISITIONS

TABLE 61: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 62: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 63: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

FIGURE LIST

FIGURE 1: PREVALENCE OF DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES 2019

FIGURE 2: KEY MARKET TRENDS

FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020

FIGURE 7: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY INDICATIONS, IN 2020

FIGURE 10: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNELS, IN 2020

FIGURE 15: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2020

FIGURE 19: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TOPICAL HAIR LOSS TREATMENT, IN 2020

FIGURE 21: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

FIGURE 24: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY ORAL HAIR LOSS TREATMENT, IN 2020

FIGURE 25: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 27: GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER TREATMENT TYPES, 2021-2028 (IN $ MILLION)

FIGURE 28: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 29: UNITED STATES ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: CANADA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 32: UNITED KINGDOM ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: GERMANY ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: FRANCE ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: ITALY ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: RUSSIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: BELGIUM ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: POLAND ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 39: REST OF EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 40: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 41: CHINA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 42: JAPAN ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 43: INDIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: SOUTH KOREA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 45: INDONESIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: THAILAND ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 47: VIETNAM ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: AUSTRALIA & NEW ZEALAND ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 49: REST OF ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 50: REST OF WORLD ALOPECIA (HAIR LOSS) TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 51: LATIN AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

FIGURE 52: MIDDLE EAST & AFRICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

  1. MARKET BY GENDER
    • FEMALE
    • MALE
  2. MARKET BY INDICATIONS
    • ANDROGENIC ALOPECIA
    • ALOPECIA AREATA
    • ALOPECIA TOTALIS
    • OTHER INDICATIONS
  3. MARKET BY DISTRIBUTION CHANNELS
    • DRUG STORES & RETAIL PHARMACIES
    • HOSPITAL PHARMACIES
    • ONLINE PHARMACIES
  4. MARKET BY TREATMENT
    • TOPICAL
      • MINOXIDIL
      • SHAMPOOS
    • ORAL
      • FINASTERIDE
      • OTHER ORAL HAIR LOSS TREATMENT
    • OTHER TREATMENT TYPES
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Choose License Type